Marriage Counselors in Odgen, UT Accepting Medicare
1 Marriage Counselors found. Showing 1 - 1
 John T Evans, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 237 26th Street, Odgen, UT 84401 Phone: 801-625-3605 Fax: 801-625-3615 |
News Archive
FDA advisory committee backs Takeda's vedolizumab for treatment of ulcerative colitis, Crohn's disease
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that a joint panel of members from the Gastrointestinal Drugs and Drug Safety and Risk Management Advisory Committees of the United States Food and Drug Administration voted to recommend approval of Takeda's vedolizumab for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease.
Study explores link between assisted reproduction and prostate cancer risk
In a new national register study from Lund University in Sweden, researchers have studied the link between prostate cancer and infertility. The study, published in the British Medical Journal, includes over one million Swedish men.
Global food security fund announces $97M in grants for Ethiopia, Mongolia, Niger
The Global Agriculture and Food Security Program (GAFSP) has awarded a second round of grants worth $97 million to Ethiopia, Mongolia and Niger for projects aimed at fighting hunger and poverty, the U.S. Treasury Department said on Thursday, Agence France-Presse reports.
Black NSCLC patients receiving immunotherapy have lower risk of death than white counterparts
Non-Hispanic Black patients with non-small cell lung cancer (NSCLC) who were treated with immunotherapy had a lower risk of death than their non-Hispanic white counterparts treated with immunotherapy, according to results presented at the virtual 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held October 6-8, 2021.
RXi's dermal anti-scarring candidate selected to advance into development
RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, today announced the selection of its first RNAi therapeutic product candidate to advance into development.
› Verified 5 days ago